A detailed history of Ipswich Investment Management Co., Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 20,227 shares of NVS stock, worth $2.11 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
20,227
Previous 20,231 0.02%
Holding current value
$2.11 Million
Previous $2.15 Million 8.04%
% of portfolio
0.56%
Previous 0.52%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$106.13 - $120.89 $424 - $483
-4 Reduced 0.02%
20,227 $2.33 Million
Q2 2024

Jul 16, 2024

BUY
$92.57 - $107.37 $370 - $429
4 Added 0.02%
20,231 $2.15 Million
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $58,732 - $65,180
620 Added 3.16%
20,227 $2.06 Million
Q2 2023

Jul 27, 2023

SELL
$92.52 - $104.91 $129,528 - $146,874
-1,400 Reduced 6.66%
19,607 $1.98 Million
Q1 2023

Apr 24, 2023

BUY
$80.03 - $92.81 $120,045 - $139,215
1,500 Added 7.69%
21,007 $1.93 Million
Q4 2022

Feb 01, 2023

SELL
$75.55 - $92.52 $488,279 - $597,956
-6,463 Reduced 24.89%
19,507 $1.77 Million
Q3 2022

Oct 11, 2022

SELL
$74.61 - $87.26 $154,293 - $180,453
-2,068 Reduced 7.38%
25,970 $1.97 Million
Q2 2022

Jul 26, 2022

SELL
$80.52 - $93.75 $165,549 - $192,750
-2,056 Reduced 6.83%
28,038 $2.37 Million
Q1 2022

Apr 12, 2022

BUY
$80.11 - $90.62 $128,176 - $144,992
1,600 Added 5.62%
30,094 $2.64 Million
Q4 2021

Jan 24, 2022

BUY
$79.7 - $88.13 $268,987 - $297,438
3,375 Added 13.44%
28,494 $2.49 Million
Q3 2021

Oct 07, 2021

SELL
$81.78 - $95.14 $40,890 - $47,570
-500 Reduced 1.95%
25,119 $2.05 Million
Q2 2021

Aug 05, 2021

SELL
$85.24 - $94.15 $5,966 - $6,590
-70 Reduced 0.27%
25,619 $2.34 Million
Q1 2021

Apr 09, 2021

SELL
$83.5 - $98.47 $48,096 - $56,718
-576 Reduced 2.19%
25,689 $2.2 Million
Q4 2020

Feb 05, 2021

SELL
$78.07 - $94.43 $23,264 - $28,140
-298 Reduced 1.12%
26,265 $2.48 Million
Q3 2020

Oct 06, 2020

SELL
$82.14 - $91.0 $8,214 - $9,100
-100 Reduced 0.38%
26,563 $2.31 Million
Q1 2020

Apr 09, 2020

SELL
$70.67 - $99.01 $190,809 - $267,327
-2,700 Reduced 9.2%
26,663 $2.2 Million
Q1 2019

Apr 12, 2019

SELL
$75.32 - $86.15 $7,531 - $8,615
-100 Reduced 0.34%
29,363 $2.82 Million
Q4 2018

Jan 15, 2019

BUY
$73.66 - $82.02 $315,117 - $350,881
4,278 Added 16.99%
29,463 $2.53 Million
Q3 2018

Oct 09, 2018

SELL
$66.94 - $77.43 $9,706 - $11,227
-145 Reduced 0.57%
25,185 $2.17 Million
Q2 2018

Jul 18, 2018

BUY
$64.91 - $73.36 $97,365 - $110,040
1,500 Added 6.29%
25,330 $1.91 Million
Q1 2018

Apr 12, 2018

BUY
$70.39 - $84.15 $101,502 - $121,344
1,442 Added 6.44%
23,830 $1.93 Million
Q3 2017

Oct 11, 2017

BUY
$74.14 - $77.27 $1.66 Million - $1.73 Million
22,388
22,388 $1.92 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ipswich Investment Management Co., Inc. Portfolio

Follow Ipswich Investment Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.